Characteristics of patients with NHL in the pre- and post-HAART eras
. | Pre-HAART 1986-95 . | Post-HAART 1996-99 . | χ2Pvalue . |
---|---|---|---|
New cases NHL | 99 | 51 | |
Prior AIDS | 57% | 34% | .007 |
Stage I | 31% | 14% | .0665-150 |
Stage II | 6% | 10% | |
Stage III | 4% | 8% | |
Stage IV | 59% | 68% | |
B symptoms | 75% | 85% | .180 |
Bone marrow involvement | 19% | 22% | .730 |
ECOG > 2 | 50% | 42% | .278 |
CD4 < 100 cells/mm3 | 73% | 37% | <.001 |
CD4 median (range) cells/mm3 | 38 (2-763) | 130 (2-636) | .00215-151 |
Mean age at NHL (y) | 37.9 (SD = 8.3) | 43.9 (SD = 9.0) | .00015-152 |
. | Pre-HAART 1986-95 . | Post-HAART 1996-99 . | χ2Pvalue . |
---|---|---|---|
New cases NHL | 99 | 51 | |
Prior AIDS | 57% | 34% | .007 |
Stage I | 31% | 14% | .0665-150 |
Stage II | 6% | 10% | |
Stage III | 4% | 8% | |
Stage IV | 59% | 68% | |
B symptoms | 75% | 85% | .180 |
Bone marrow involvement | 19% | 22% | .730 |
ECOG > 2 | 50% | 42% | .278 |
CD4 < 100 cells/mm3 | 73% | 37% | <.001 |
CD4 median (range) cells/mm3 | 38 (2-763) | 130 (2-636) | .00215-151 |
Mean age at NHL (y) | 37.9 (SD = 8.3) | 43.9 (SD = 9.0) | .00015-152 |